{"database":"iProX","file_versions":[],"scores":null,"additional":{"omics_type":["Proteomics"],"submitter":["Magdalena Luczak"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.iprox.org/page/project.html?id=IPX0016790000"],"submitter_email":["magdalu@ibch.poznan.pl"],"submitter_affiliation":["Institute of Bioorganic Chemistry Polish Academy of Sciences"],"sample_protocol":[""],"repository":["iProX"],"data_protocol":[""],"additional_accession":[]},"is_claimable":false,"name":"Proteomic profiling of  proteasome inhibitor-resistant multiple myeloma cells","description":"Acquired resistance to proteasome inhibitors remains a major therapeutic challenge in multiple myeloma. In this study, we investigated mechanisms underlying resistance to bortezomib and carfilzomib using comprehensive proteomic profiling of RPMI8226 and U266B1 cell lines across different stages of resistance evolution.","dates":{"publication":"Fri Apr 24 00:00:00 GMT+01:00 2026"},"accession":"PXD077551","cross_references":{"TAXONOMY":["9606"]}}